IP Library Granted Patent US 9,687,589
Granted Patent B2
US 9,687,589 · App. 14/760,187 · Granted Jun 27, 2017

Oxygenated three-dimensional matrix for bone growth

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,687,589
App. No.
14/760,187
Granted
Jun 27, 2017
Kind
B2
Abstract

An encapsulated three-dimensional (3-D) bone matrix composition for inducing bone growth includes a 3-D bone matrix, an oxygen carrier incorporated into the 3-D bone matrix, and an encapsulation material which encapsulates the 3-D bone matrix incorporated with the oxygen carrier. Methods are disclosed for preparing an encapsulated 3-D bone matrix that can be maintained in packaging.

Claims (9)

1. An encapsulated 3-dimensional (3-D) bone matrix composition for inducing bone growth, comprising:

a 3-D bone matrix selected from a demineralized cancellous sponge or a non-demineralized cancellous bone strip;

an oxygen carrier incorporated into the 3-D bone matrix; and

an encapsulation material that encapsulates the 3-D bone matrix.

2. The encapsulated 3-D bone matrix composition of claim 1 , wherein the oxygen carrier is selected from the group consisting of perfluorodecalin, perfluorohexane, perfluoroperhydrophenanthrene, perfluorobutylamine (PFTBA or PFTBM), perfluorooctylbromide (PFOB), perfluoro-n-octane, octafluoropropane, perfluorodichlorooctane, perfluorodecane, perfluorotripropylamine, perfluorotrimethylcyclohexane, perfluoromethyladamantane, perfluorodimethyladamantane, perfluoromethyldecaline, perfluorofluorene, diphenyldimethylsiloxane, monohydroperfluorooctane, alumina-treated perfluorooctane, and mixtures thereof.

3. The encapsulated 3-D bone matrix composition of claim 1 , wherein the encapsulation material is a collagen-derived material.

4. The encapsulated 3-D bone matrix composition of claim 1 , further comprising a demineralized bone matrix powder mixed with the oxygen carrier.

5. The encapsulated 3-D bone matrix composition of claim 1 , further comprising a dispersing agent mixed with the oxygen carrier.

6. The encapsulated 3-D bone matrix composition of claim 5 , wherein the dispersing agent is selected from the group consisting of glycerols, lecithins, polyoxamers, surfactants, and phospholipids.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2025
From: THERACELL, LLC
To: ARTERIOCYTE MEDICAL SYSTEMS, INC.
Reel/Frame 072388/0197 →
SECURITY INTEREST Recorded Sep 18, 2025
From: ISTO TECHNOLOGIES II, LLC; ADVANCED BIOLOGICS LLC,; ARTERIOCYTE MEDICAL SYSTEMS, INC.; THERACELL, LLC
To: GOLUB CAPITAL MARKETS LLC
Reel/Frame 072300/0216 →
RELEASE OF SECURITY INTEREST Recorded Sep 16, 2025
From: BARINGS FINANCE LLC, AS COLLATERAL AGENT
To: ARTERIOCYTE MEDICAL SYSTEMS, INC.; ISTO TECHNOLOGIES II, LLC; THERACELL, LLC; ADVANCED BIOLOGICS, LLC; BIOLOGICA TECHNOLOGIES, LLC
Reel/Frame 072274/0408 →
RELEASE OF SECURITY INTEREST Recorded Oct 18, 2023
From: TWIN BROOK CAPITAL PARTNERS, LLC
To: ISTO TECHNOLOGIES II, LLC
Reel/Frame 065269/0604 →
SECURITY INTEREST Recorded Oct 18, 2023
From: ARTERIOCYTE MEDICAL SYSTEMS, INC.; ISTO TECHNOLOGIES II, LLC; THERACELL, LLC; ADVANCED BIOLOGICS, LLC; BIOLOGICA TECHNOLOGIES, LLC
To: BARINGS FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065271/0059 →
CHANGE OF NAME Recorded Oct 11, 2023
From: THERACELL, INC.
To: THERACELL, LLC
Reel/Frame 065219/0102 →
SECURITY INTEREST Recorded Apr 4, 2022
From: THERACELL, INC.
To: TWIN BROOK CAPITAL PARTNERS, LLC, AS AGENT
Reel/Frame 059486/0202 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2015
From: CARTER, ANDREW J.; SCARBOROUGH, NELSON L.; PHILLIPS, FRANK M.; HOCHSCHULER, STEPHEN H.; PATT, BRADLEY
To: THERACELL, INC.
Reel/Frame 036293/0084 →